Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 09/06/24
Senseonics Holdings, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for August 8, 2024 at 4:30 P.M. Eastern TimeBusiness Wire • 07/25/24
Senseonics Holdings, Inc. Provides Business Update and Full Year 2024 Financial OutlookBusiness Wire • 06/21/24
Senseonics Holdings, Inc. to Host Business Update and Analyst Event During the American Diabetes Association's 84th Scientific SessionsBusiness Wire • 06/13/24
Senseonics and Mercy Collaborate to Improve Diabetes Population Health ManagementBusiness Wire • 05/13/24
Senseonics Holdings, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 13, 2024 at 4:30 P.M. Eastern TimeBusiness Wire • 04/30/24
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMSPRNewsWire • 03/12/24
Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for DiabetesBusiness Wire • 03/08/24
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services ConferenceBusiness Wire • 03/06/24
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/01/24
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial ResultsBusiness Wire • 02/29/24
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern TimeBusiness Wire • 02/15/24